HomeInsightsMarket Capitalization

Market Capitalization of Zydus Lifesciences Ltd

Market Capitalization of Zydus Lifesciences Ltd

stocks purchased

₹ 1.4 Cr

Volume transacted

stocks purchased

13.1 K

stocks traded

Last Updated time: 10 Oct 15:30 PM

Image

Zydus Lifesciences Ltd

NSE: ZYDUSLIFE

MARKETCAP

106358.93 crore

Last updated: 10 Oct 24

Key Highlights

  • The Market Cap of Zydus Lifesciences Ltd is ₹ 106358 crore as of 10 Oct 24.
  • The Market Cap of Zydus Lifesciences Ltd changed from ₹ 35482 crore on March 2019 to ₹ 101151 crore on March 2024 . This represents a CAGR of 19.08% over 6 years. .
  • The Latest Trading Price of Zydus Lifesciences Ltd is ₹ 1057 as of 10 Oct 15:30.

Historical Market Cap of Zydus Lifesciences Ltd

No data available

* All values are in crore

Company Fundamentals for Zydus Lifesciences Ltd

No data available

Image

Zydus Lifesciences Ltd

NSE: ZYDUSLIFE

PRICE

1057

-8.15 (-0.77%)

stock direction

Last updated: 10 Oct 15:30

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Zydus Lifesciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
10 Oct 20241057
09 Oct 20241065.15
08 Oct 20241054.15
07 Oct 20241050.9
04 Oct 20241057.35
03 Oct 20241068.85
01 Oct 20241080.6
30 Sep 20241068.35
27 Sep 20241074.6
26 Sep 20241068.35

SWOT Analysis Of Zydus Lifesciences Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

2

T

BlinkX Score for Zydus Lifesciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Zydus Lifesciences Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Zydus Lifesciences Ltd251,06,358
Sun Pharmaceuticals Industries Ltd434,63,360
Divis Laboratories Ltd941,58,943
Cipla Ltd301,35,756
Torrent Pharmaceuticals Ltd721,20,439
Dr Reddys Laboratories Ltd201,11,289

Key Valuation Metric of Zydus Lifesciences Ltd

No data available

Historical P/E Ratio of Zydus Lifesciences Ltd

No data available

* All values are in %

Historical Revenue of Zydus Lifesciences Ltd

No data available

* All values are in crore

Historical EBITDA of Zydus Lifesciences Ltd

No data available

* All values are in crore

Historical Net Profit of Zydus Lifesciences Ltd

No data available

* All values are in crore

Historical Dividend Payout of Zydus Lifesciences Ltd

No data available

* All values are in %

About Zydus Lifesciences Ltd

  • Zydus Lifesciences Ltd. (Formerly known as Cadila Healthcare Ltd.) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain including innovating (research & development), manufacturing, marketing and selling of finished dosage human formulations (generics, branded generics and specialty formulations, including biosimilars and vaccines), Active Pharmaceutical Ingredients (APIs), animal healthcare products and consumer wellness products. The Company operate manufacturing facilities at Ahmedabad, Ankleshwar and Vadodara in Gujarat, Ponda in Goa, Raigad in Maharashtra and Solan in Himachal Pradesh. Founded by the Late Promoter, Mr. Ramanbhai B. Patel, the Company was incorporated in May, 1995 and converted into a Public Limited Company in July, 1996.

Zydus Lifesciences Ltd News Hub

News

Zydus receives USFDA approval for Paliperidone Extended-Release Tablets

Zydus Lifesciences has received final approval from the United States Food and Drug Admini...

Read more

10 Oct 202416:08

News

Zydus Life gets final approval from USFDA for Paliperidone drug

Paliperidone extended-release tablets are indicated for the acute and maintenance treatmen...

Read more

10 Oct 202414:51

News

Zydus' transdermal patch manufacturing facility completes USFDA inspection

Zydus Lifesciences has received the EIR report from the USFDA for the inspection conducted...

Read more

01 Oct 202412:26

News

Zydus Life's Ahmedabad facility gets EIR from USFDA

The USFDA conducted an inspection from 15 to 19 July 2024, and has been classified as Volu...

Read more

01 Oct 202412:13

News

Zydus receives USFDA approval for Enzalutamide capsules

Zydus Lifesciences has received final approval from the United States Food and Drug Admini...

Read more

28 Sep 202414:21

News

Zydus Life gets final approval from USFDA for cancer drug

The Enzalutamide capsules are androgen receptor inhibitors indicated for the treatment of ...

Read more

28 Sep 202414:42

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for Market Cap of Zydus Lifesciences Ltd

What is the market cap of Zydus Lifesciences Ltd?

As of October 10, 2024, Zydus Lifesciences Ltd has a market capitalization of ₹106358.93, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Zydus Lifesciences Ltd's market capitalization?

Zydus Lifesciences Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Zydus Lifesciences Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Zydus Lifesciences Ltd's market capitalization change?

Zydus Lifesciences Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*